Cite Filings / WHWK / 0000950170-24-139724
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13D/A

Beneficial Ownership Report

Whitehawk Therapeutics, Inc. · Filed 2024-12-23 · Acc 0000950170-24-139724

Documents 1

  • SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

  • 2025-01-24 SCHEDULE 13D/A Beneficial Ownership Report
  • 2024-12-23 4 Options or other derivatives
  • 2024-12-23 3 Initial Statement of Ownership
  • 2024-12-23 SCHEDULE 13D/A Beneficial Ownership Report
  • 2024-12-23 SCHEDULE 13D/A Beneficial Ownership Report
  • 2024-12-20 DEFA14A Proxy Materials
  • 2024-12-20 8-K Material agreement · Unregistered share sale · Executive or director change · Regulation FD disclosure

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · Dellora Investments LP 5.6%
  2. 2026-11-16 SCHEDULE 13G/A · ABG Global Life Science Capital Partners V GP Limited 7.8%
  3. 2026-11-13 SCHEDULE 13G/A · Coastlands Capital LP 6.19%
Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…